Monocyte-to-high-density lipoprotein ratio and systemic immune-inflammation index: Potential parameters for the evaluation of disease activity and severity in Graves' ophthalmopathy?
Graves’ ophthalmopathy
Inflammation
Monocyte-to-high-density lipoprotein ratio
Neutrophil-to-lymphocyte ratio
Systemic immune-inflammation index
Journal
International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294
Informations de publication
Date de publication:
21 Mar 2024
21 Mar 2024
Historique:
received:
20
10
2023
accepted:
16
02
2024
medline:
21
3
2024
pubmed:
21
3
2024
entrez:
21
3
2024
Statut:
epublish
Résumé
To assess changes in monocyte-to-high-density lipoprotein (HDL) ratio (MHR), neutrophil-to-lymphocyte ratio (NLR), and systemic immune-inflammation index (SII) with Graves' ophthalmopathy (GO) and their possible relation with GO disease activity and severity. A total of 20 patients with GO and 24 healthy controls were involved in the study. The thyroid status, MHR (monocyte count/HDL cholesterol level), NLR (neutrophil count/lymphocyte count) and SII [(neutrophil count × platelet count)/lymphocyte count] were compared between the groups. The relation of systemic inflammation parameters with disease activity and severity was evaluated. The mean Clinical Activity Score (CAS) was 0.75 ± 0.78 in the GO group. None of the patients were active. The severity was mild for 14 (70.0%) patients and moderate-to-severe for 6 (30.0%) patients. MHR (17.28 ± 5.56 vs. 13.28 ± 5.08), NLR (2.51 ± 1.09 vs. 1.69 ± 0.53) and SII [600.42 (391.79-837.16) vs. 413.69 (344.26-603.82)] values were significantly increased in GO patients than in the controls (p = 0.017, p = 0.005 and p = 0.036, respectively). CAS was significantly correlated with MHR (r = 0.815, p < 0.001), NLR (r = 0.768, p = 0.017) and SII (r = 0.837, p < 0.001). The severity of GO was associated with increased MHR, NLR and SII (p = 0.019, p = 0.036 and p = 0.008, respectively). ROC analysis demonstrated that MHR, NLR and SII have a good ability to differentiate GO patients from healthy individuals. GO patients have higher MHR and SII levels than healthy controls. Higher MHR, NLR and SII values were associated with increasing disease severity and activity, supporting the efficacy of these non-invasive, low-cost markers in determining the course of GO. Future prospective controlled trials are needed to elucidate the relation between inflammatory markers and GO.
Identifiants
pubmed: 38509387
doi: 10.1007/s10792-024-03077-x
pii: 10.1007/s10792-024-03077-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
154Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Hiromatsu Y, Eguchi H, Tani J, Kasaoka M, Teshima Y (2014) Graves’ ophthalmopathy: epidemiology and natural history. Intern Med 53:353–360. https://doi.org/10.2169/internalmedicine.53.1518
doi: 10.2169/internalmedicine.53.1518
pubmed: 24583420
Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, Perros P, Salvi M, Wiersinga WM, European Group on Graves’ Orbitopathy (EUGOGO) (2016) The 2016 European Thyroid Association/European Group on Graves’ Orbitopathy Guidelines for the Management of Graves’ Orbitopathy. Eur Thyroid J 5:9–26. https://doi.org/10.1159/000443828
doi: 10.1159/000443828
pubmed: 27099835
pmcid: 4836120
Khong JJ, McNab AA, Ebeling PR, Craig JE, Selva D (2016) Pathogenesis of thyroid eye disease: review and update on molecular mechanisms. Br J Ophthalmol 100:142–150. https://doi.org/10.1136/bjophthalmol-2015-307399
doi: 10.1136/bjophthalmol-2015-307399
pubmed: 26567024
Li N (2008) Platelet-lymphocyte cross-talk. J Leukoc Biol 83:1069–1078. https://doi.org/10.1189/jlb.0907615
doi: 10.1189/jlb.0907615
pubmed: 18198208
Zahorec R (2001) Ratio of neutrophil to lymphocyte counts–rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 102:5–14
pubmed: 11723675
Celik T (2018) Assessment of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with dry eye disease. Ocul Immunol Inflamm 26:1219–1222. https://doi.org/10.1080/09273948.2017.1340486
doi: 10.1080/09273948.2017.1340486
pubmed: 28910561
Erol MK, Balkarli A, Yucel O, Akar Y, Dogan B, Suren E (2017) Neutrophil/lymphocyte ratio and mean platelet volume in central serous chorioretinopathy. Ther Clin Risk Manag 13:945–950. https://doi.org/10.2147/TCRM.S138581
doi: 10.2147/TCRM.S138581
pubmed: 28814876
pmcid: 5545637
Katipoğlu Z, Mirza E, Oltulu R, Katipoglu B (2020) May monocyte/HDL cholesterol ratio (MHR) and neutrophil/lymphocyte ratio (NLR) be an indicator of inflammation and oxidative stress in patients with keratoconus? Ocul Immunol Inflamm 28:632–636. https://doi.org/10.1080/09273948.2019.1611876
doi: 10.1080/09273948.2019.1611876
pubmed: 31560568
Şatırtav G, Mirza E, Oltulu R, Mirza GD, Kerimoğlu H (2020) Assessment of monocyte/HDL ratio in branch retinal vein occlusion. Ocul Immunol Inflamm 28:463–467. https://doi.org/10.1080/09273948.2019.1569244
doi: 10.1080/09273948.2019.1569244
pubmed: 30966842
Tang B, Li S, Han J, Cao W, Sun X (2020) Associations between blood cell profiles and primary open-angle glaucoma: a retrospective case-control study. Ophthalmic Res 63:413–422. https://doi.org/10.1159/000504450
doi: 10.1159/000504450
pubmed: 32018245
Atılgan CÜ, Şendül SY, Kösekahya P, Çağlayan M, Alkan A, Güven D et al (2018) Evaluation of neutrophil-to-lymphocyte ratio and mean platelet volume in patients with active and inactive thyroid orbitopathy. Sisli Etfal Hastan Tip Bul 52:26–30. https://doi.org/10.14744/SEMB.2017.07269
doi: 10.14744/SEMB.2017.07269
pubmed: 32595367
pmcid: 7315080
Celik T (2017) Neutrophil-to-lymphocyte ratio in thyroid ophthalmopathy. Bratisl Lek Listy 118:495–498. https://doi.org/10.4149/BLL_2017_095
doi: 10.4149/BLL_2017_095
pubmed: 29050489
Szydełko J, Litwińczuk M, Szydełko M, Matyjaszek-Matuszek B (2020) Neutrophil-to-lymphocyte, monocyte-to-lymphocyte and platelet-to-lymphocyte ratios in relation to clinical parameters and smoking status in patients with graves’ orbitopathy-novel insight into old tests. J Clin Med 9:3111. https://doi.org/10.3390/jcm9103111
doi: 10.3390/jcm9103111
pubmed: 32993174
pmcid: 7600876
Vural G, Gümüsyayla Ş (2018) Monocyte-to-high density lipoprotein ratio is associated with a decreased compound muscle action potential amplitude in patients with diabetic axonal polyneuropathy. Medicine (Baltimore) 97:e12857. https://doi.org/10.1097/MD.0000000000012857
doi: 10.1097/MD.0000000000012857
pubmed: 30334993
Ganjali S, Gotto AM Jr, Ruscica M, Atkin SL, Butler AE, Banach M et al (2018) Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol 233:9237–9246. https://doi.org/10.1002/jcp.27028
doi: 10.1002/jcp.27028
pubmed: 30076716
Usta A, Avci E, Bulbul CB, Kadi H, Adali E (2018) The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome. Reprod Biol Endocrinol 16:34. https://doi.org/10.1186/s12958-018-0351-0
doi: 10.1186/s12958-018-0351-0
pubmed: 29631598
pmcid: 5891948
Yılmaz M, Kayançiçek H (2018) A new inflammatory marker: elevated monocyte to HDL cholesterol ratio associated with smoking. J Clin Med 7:76. https://doi.org/10.3390/jcm7040076
doi: 10.3390/jcm7040076
pubmed: 29642607
pmcid: 5920450
Belviranli S, Oltulu R, Gundogan AO, Mirza E, Okka M (2022) Evaluation of the systemic inflammation in patients with pterygium: monocyte-to- high-density lipoprotein cholesterol ratio and hematologic indexes of inflammation. Middle East Afr J Ophthalmol 28:211–215. https://doi.org/10.4103/meajo.meajo_75_21
doi: 10.4103/meajo.meajo_75_21
pubmed: 35719292
pmcid: 9198535
Oltulu R, Katipoğlu Z, Gündoğan AO, Mirza E, Belviranlı S (2022) Evaluation of inflammatory biomarkers in patients with keratoconus. Eur J Ophthalmol 32:154–159. https://doi.org/10.1177/11206721211000644
doi: 10.1177/11206721211000644
pubmed: 33715480
Zhang J, Li Y, Zhou Y, Wang K, Pan C, Zhao Y et al (2021) Monocyte to high-density lipoprotein ratio: a novel predictive marker of disease severity and prognosis in patients with neuromyelitis optica spectrum disorders. Front Neurol 12:763793. https://doi.org/10.3389/fneur.2021.763793
doi: 10.3389/fneur.2021.763793
pubmed: 34777231
pmcid: 8580507
Kim HB, Kim A, Kim Y, Kim GT, Ahn E, So MW et al (2021) Associations of serum monocyte-to-high-density lipoprotein cholesterol ratio with digital ulcers and skin fibrosis in patients with systemic sclerosis. Scand J Rheumatol 50:231–238. https://doi.org/10.1080/03009742.2020.1837237
doi: 10.1080/03009742.2020.1837237
pubmed: 33243053
Ci W, Wan J, Han J, Zou K, Ge C, Pan L et al (2023) Monocyte-to-high-density lipoprotein ratio as a predictor for patients with Takayasu arteritis and coronary involvement: a double-center, observational study. Front Immunol 14:1120245. https://doi.org/10.3389/fimmu.2023.1120245
doi: 10.3389/fimmu.2023.1120245
pubmed: 37426640
pmcid: 10324657
López P, Rodríguez-Carrio J, Martínez-Zapico A, Pérez-Álvarez ÁI, Suárez-Díaz S, Mozo L et al (2020) Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus. Rheumatology (Oxford) 59:1752–1764. https://doi.org/10.1093/rheumatology/keaa016.Erratum.In:Rheumatology(Oxford).2020;59:1795
doi: 10.1093/rheumatology/keaa016.Erratum.In:Rheumatology(Oxford).2020;59:1795
pubmed: 32031658
Uslu AU, Küçük A, Şahin A, Ugan Y, Yılmaz R, Güngör T et al (2015) Two new inflammatory markers associated with Disease Activity Score-28 in patients with rheumatoid arthritis: neutrophil-lymphocyte ratio and platelet-lymphocyte ratio. Int J Rheum Dis 18:731–735. https://doi.org/10.1111/1756-185X.12582
doi: 10.1111/1756-185X.12582
pubmed: 25900081
Lee HN, Kim YK, Kim GT, Ahn E, So MW, Sohn DH et al (2019) Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as predictors of 12-week treatment response and drug persistence of anti-tumor necrosis factor-α agents in patients with rheumatoid arthritis: a retrospective chart review analysis. Rheumatol Int 39:859–868. https://doi.org/10.1007/s00296-019-04276-x
doi: 10.1007/s00296-019-04276-x
pubmed: 30874873
Duru Z, Altunel O, Alabay B, Sirakaya E, Sirakaya E, Kucuk B et al (2021) Elevated monocyte-to-high-density lipoprotein ratio as an indicator of systemic inflammation in patients with branch retinal vein occlusion. Beyoglu Eye J 6:212–216. https://doi.org/10.14744/bej.2021.94547
doi: 10.14744/bej.2021.94547
pubmed: 35005518
pmcid: 8697051
Tang X, Tan Y, Yang Y, Li M, He X, Lu Y et al (2021) Association of the monocyte-to-high-density lipoprotein cholesterol ratio with diabetic retinopathy. Front Cardiovasc Med 8:707008. https://doi.org/10.3389/fcvm.2021.707008
doi: 10.3389/fcvm.2021.707008
pubmed: 34621797
pmcid: 8490616
Mirza E, Oltulu R, Katipoğlu Z, Mirza GD, Özkağnıcı A (2020) Monocyte/HDL ratio and lymphocyte/monocyte ratio in patients with pseudoexfoliation syndrome. Ocul Immunol Inflamm 28:142–146. https://doi.org/10.1080/09273948.2018.1545913
doi: 10.1080/09273948.2018.1545913
pubmed: 30422026
Fu S, Yan J, Tan Y, Liu D (2021) Prognostic value of systemic immune-inflammatory index in survival outcome in gastric cancer: a meta-analysis. J Gastrointest Oncol 12:344–354. https://doi.org/10.21037/jgo-20-252
doi: 10.21037/jgo-20-252
pubmed: 34012630
pmcid: 8107617
Fois AG, Paliogiannis P, Scano V, Cau S, Babudieri S, Perra R et al (2020) The systemic inflammation index on admission predicts in-hospital mortality in COVID-19 patients. Molecules 25:5725. https://doi.org/10.3390/molecules25235725
doi: 10.3390/molecules25235725
pubmed: 33291581
pmcid: 7731255
Yang YL, Wu CH, Hsu PF, Chen SC, Huang SS, Chan WL et al (2020) Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest 50:e13230. https://doi.org/10.1111/eci.13230
doi: 10.1111/eci.13230
pubmed: 32291748
Zuo W, Chen T, Song J, Ai M (2023) Assessment of systemic immune-inflammation index levels in patients with retinal vein occlusion. Ocul Immunol Inflamm 31:491–495. https://doi.org/10.1080/09273948.2022.2032199
doi: 10.1080/09273948.2022.2032199
pubmed: 35201964
Ozarslan Ozcan D, Kurtul BE, Ozcan SC, Elbeyli A (2022) Increased systemic immune-inflammation index levels in patients with dry eye disease. Ocul Immunol Inflamm 30:588–592. https://doi.org/10.1080/09273948.2020.1821899
doi: 10.1080/09273948.2020.1821899
pubmed: 32990489
Kurtul BE, Cakmak AI, Elbeyli A, Ozcan SC, Ozarslan Ozcan D, Kimyon G (2021) Evaluation of systemic immune-inflammation index level as a novel marker for severity of noninfectious uveitis. Int Ophthalmol 41:3615–3622. https://doi.org/10.1007/s10792-021-01924-9
doi: 10.1007/s10792-021-01924-9
pubmed: 34432177
Yavuz S, Ece A (2014) Mean platelet volume as an indicator of disease activity in juvenile SLE. Clin Rheumatol 33:637–641. https://doi.org/10.1007/s10067-014-2540-3
doi: 10.1007/s10067-014-2540-3
pubmed: 24567240
Ozdemir R, Karadeniz C, Doksoz O, Celegen M, Yozgat Y, Guven B et al (2014) Are mean platelet volume and platelet distribution width useful parameters in children with acute rheumatic carditis? Pediatr Cardiol 35:53–56. https://doi.org/10.1007/s00246-013-0738-9
doi: 10.1007/s00246-013-0738-9
pubmed: 23780555
Tecer D, Sezgin M, Kanık A, İncel NA, Çimen ÖB, Biçer A, Şahin G et al (2016) Can mean platelet volume and red blood cell distribution width show disease activity in rheumatoid arthritis? Biomark Med 10:967–974. https://doi.org/10.2217/bmm-2016-0148
doi: 10.2217/bmm-2016-0148
pubmed: 27564580
Sepas HN, Negahi A, Mousavie SH, Nasiri M (2019) Evaluation of the potential association of platelet levels, mean platelet volume and platelet distribution width with acute appendicitis. Open Access Maced J Med Sci 7:2271–2276. https://doi.org/10.3889/oamjms.2019.244
doi: 10.3889/oamjms.2019.244
pubmed: 31592065
pmcid: 6765097